{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:01:02Z","timestamp":1792875662941,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.clinthera.2006.01.010","type":"journal-article","created":{"date-parts":[[2006,2,19]],"date-time":"2006-02-19T07:15:17Z","timestamp":1140333317000},"page":"86-98","source":"Crossref","is-referenced-by-count":21,"title":["Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain"],"prefix":"10.1016","volume":"28","author":[{"given":"Sharon M.","family":"Weinstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minggao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica A","family":"Kwarcinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2006.01.010_bib1","series-title":"Opioid Analgesia: Recent Advances in Systemic Administration","first-page":"425","article-title":"Systemic opioids for the management of cancer pain: An updated review","volume":"vol 14","author":"Bonica","year":"1990"},{"key":"10.1016\/j.clinthera.2006.01.010_bib2","series-title":"Cancer Pain Relief","year":"1986"},{"key":"10.1016\/j.clinthera.2006.01.010_bib3","series-title":"Management of Cancer Pain","author":"Jacox","year":"1994"},{"key":"10.1016\/j.clinthera.2006.01.010_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00003495-199142020-00005","article-title":"Treatment principles for the use of opioids in pain of nonmalignant origin","volume":"42","author":"Schug","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2006.01.010_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0885-3924(92)90116-Y","article-title":"Long-term oral opioid therapy in patients with chronic nonmalignant pain","volume":"7","author":"Zenz","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2006.01.010_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0885-3924(95)00187-5","article-title":"Opioid therapy for chronic nonmalignant pain: A review of the critical issues","volume":"11","author":"Portenoy","year":"1996","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2006.01.010_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00002508-199703000-00003","article-title":"The use of opioids for the treatment of chronic pain","volume":"13","author":"A consensus statement from the American Academy of Pain Medicine and the American Pain Society","year":"1997","journal-title":"Clin J Pain"},{"key":"10.1016\/j.clinthera.2006.01.010_bib8","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archinte.160.6.853","article-title":"Aroundthe-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: Placebo-controlled trial and long-term evaluation","volume":"160","author":"Roth","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2006.01.010_bib9","first-page":"1463","article-title":"Our experience with Dilaudid [in German]","volume":"70","author":"Lullies","year":"1929","journal-title":"Munch Med Wochenschr"},{"key":"10.1016\/j.clinthera.2006.01.010_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1056\/NEJM198507113130205","article-title":"The treatment of cancer pain","volume":"313","author":"Foley","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2006.01.010_bib11","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y","article-title":"Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain","volume":"74","author":"Hays","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.clinthera.2006.01.010_bib12","series-title":"Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain","author":"American Pain Society","year":"2003"},{"key":"10.1016\/j.clinthera.2006.01.010_bib13","series-title":"Opioid Analgesics in the Management of Clinical Pain","first-page":"87","article-title":"Commentary: Equianalgesic dose ratio of intramuscular\/oral morphine, 1:6 versus 1:3","volume":"vol 8","author":"Kaiko","year":"1986"},{"key":"10.1016\/j.clinthera.2006.01.010_bib14","first-page":"713","article-title":"Opioid analgesics. Comparative features and prescribing guidelines","volume":"51","author":"Cherry","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2006.01.010_bib15","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","first-page":"569","article-title":"Opioid analgesics","author":"Gutstein","year":"2001"},{"key":"10.1016\/j.clinthera.2006.01.010_bib16","series-title":"Clinical Pharmacology","first-page":"59","article-title":"Evaluation of analgesics in patients with cancer pain","volume":"vol 1","author":"Houde","year":"1966"},{"key":"10.1016\/j.clinthera.2006.01.010_bib17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jpainsymman.2004.10.008","article-title":"Comparative efficacy of oral extended-release hydromorphone and immediate-release hydromorphone in patients with persistent moderate to severe pain: Two randomized controlled trials","volume":"29","author":"Grosset","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2006.01.010_bib18","author":"World Medical Association Declaration of Helsinki"},{"key":"10.1016\/j.clinthera.2006.01.010_bib19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/00000542-197505000-00021","article-title":"Relative analgesic potencies of morphine and hydromorphone in postoperativepain","volume":"42","author":"Mahler","year":"1975","journal-title":"Anesthesiology"},{"key":"10.1016\/j.clinthera.2006.01.010_bib20","series-title":"Opioid Analgesics in the Management of Clinical Pain","first-page":"129","article-title":"Clinical analgesic studies of hydromorphone","volume":"vol 8","author":"Houde","year":"1986"},{"key":"10.1016\/j.clinthera.2006.01.010_bib21","first-page":"1","article-title":"A randomised crossover comparison of controlled release hydro morphone tablets with controlled release morphine tablets in patients with cancerpain","volume":"2","author":"Moriarty","year":"1999","journal-title":"J Clin Res"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2006.01.010_bib22","first-page":"522","article-title":"Steady-state pharmacokinetic comparison ofa once-a-day controlled release hydromorphone hydrochloride capsule vs. immediate-release hydromorphonehydrochloride tablet","volume":"21","author":"Rosen","year":"1998","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.clinthera.2006.01.010_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3959(83)90143-4","article-title":"Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases","volume":"17","author":"Daut","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2006.01.010_bib24","series-title":"National Adverse Drug Reaction Directory; COSTART (Coding Symbols for Thesaurus of Adverse Reaction Terms)^","year":"1995"},{"key":"10.1016\/j.clinthera.2006.01.010_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/j.1552-4604.1996.tb04223.x","article-title":"Analgesic efficacy of controlledrelease oxycodone in postoperative pain","volume":"36","author":"Sunshine","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2006.01.010_bib26","series-title":"Guideline for the Clinical Evaluation of Analgesic Drugs","year":"1992"},{"key":"10.1016\/j.clinthera.2006.01.010_bib27","series-title":"The Design of Analgesic Clinical Trials","first-page":"55","article-title":"Single-dose analgesic comparisons","volume":"vol 18","author":"Max","year":"1991"},{"key":"10.1016\/j.clinthera.2006.01.010_bib28","series-title":"Analgetics","first-page":"75","article-title":"Clinical measurement of pain","author":"Houde","year":"1965"},{"key":"10.1016\/j.clinthera.2006.01.010_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.pain.2005.03.004","article-title":"MorphiDex (morphine sulfate\/ dextromethorphan hydrobromide combination) in the treatment of chronic pain: Three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance","volume":"115","author":"Galer","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2006.01.010_bib30","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1200\/JCO.1998.16.10.3230","article-title":"Comparison of controlledrelease and immediate-release oxyco done tablets in patients with cancer pain","volume":"16","author":"Kaplan","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2006.01.010_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0885-3924(99)00079-2","article-title":"Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?","volume":"18","author":"Salzman","year":"1999","journal-title":"J Pain Symptom Manage"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T20:39:15Z","timestamp":1555447155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291806000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0149291806000245"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2006.01.010","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}